Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Aug 8;58(8):1070. doi: 10.3390/medicina58081070

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

APMPPE/AMIC; ICGA in a case that did not receive prednisone therapy with an evolution towards macular atrophy ODS: top frames show ICGA findings in intermediate and late phases in both eyes at presentation 3 months after the onset of disease. The bottom left frame shows active perimacular lesions less hypofluorescent than the centre (crimson arrows) that responded to prednisone therapy with regression of perimacular lesions after treatment but the persistence of centromacular atrophy (bottom right frame).